Application of Artificial Intelligence in Precision Medicine and Healthcare

NCT ID: NCT06879210

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-19

Study Completion Date

2026-07-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to propose an intelligent health robot that utilizes remote intelligent robots to assist patients with disease-related issues, enabling them to address their problems promptly.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Utilizing an information architecture system, a voice-based artificial intelligence program will be developed. The symptoms of major diseases and related knowledge will be input into this system to construct a dedicated disease platform. This platform will allow patients to remotely access it, enabling them to promptly understand and address disease-related issues, thereby improving convenience for patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myasthenia Gravis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Disease Group

In this study, patients with myasthenia gravis will be used as an example. After the patients use this disease inquiry platform, researchers will conduct interviews with them to understand their experiences and feedback.

Group Type OTHER

Mobile device.(phone)

Intervention Type DEVICE

Develop a mobile device \[Disease Assistance Consultation\] to help patients promptly understand their disease and how to care for it. After a 4-week trial period, conduct interviews with participants to determine whether using the mobile device can increase participants' knowledge and improve the quality of healthcare.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile device.(phone)

Develop a mobile device \[Disease Assistance Consultation\] to help patients promptly understand their disease and how to care for it. After a 4-week trial period, conduct interviews with participants to determine whether using the mobile device can increase participants' knowledge and improve the quality of healthcare.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients diagnosed with myasthenia gravis by a physician.
2. Age 20 years and above.
3. Able to use a smartphone.

Exclusion Criteria

1. Individuals not diagnosed with myasthenia gravis.
2. Individuals who do not use smartphones or tablets.
3. Individuals who withdraw from the group midway.
4. Individuals unwilling to participate in interviews.
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yi Ting Yeh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yi Ting Yeh

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yi Ting Yeh

New Taipei City, Tamsui District, Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

YI TIMG YEH

Role: CONTACT

+866-952-166-103

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

YI TING YEH

Role: primary

+886-952-166-103

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20221210R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.